|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G16H 40/63 | (2018.01) |
| G01N 27/3274 | (2013.01) | ||
| G01N 33/723 | (2013.01) |
| (11) | Number of the document | 2972397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14719898.0 |
| Date of filing the European patent application | 2014-03-11 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/023069 |
| Date | 2014-03-11 |
| (87) | Number | WO 2014/159333 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361781950 P | 2013-03-14 | US |
| (72) |
WU, Huan-Ping , US
|
| (73) |
Ascensia Diabetes Care Holdings AG ,
Peter-Merian Strasse 90, 4052 Basel,
CH
|
| (54) | SYSTEM ERROR COMPENSATION OF ANALYTE CONCENTRATION DETERMINATIONS |
| SYSTEM ERROR COMPENSATION OF ANALYTE CONCENTRATION DETERMINATIONS |